Correlation Between Pmv Pharmaceuticals and Accustem Sciences

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Pmv Pharmaceuticals and Accustem Sciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pmv Pharmaceuticals and Accustem Sciences into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Pmv Pharmaceuticals and Accustem Sciences, you can compare the effects of market volatilities on Pmv Pharmaceuticals and Accustem Sciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pmv Pharmaceuticals with a short position of Accustem Sciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pmv Pharmaceuticals and Accustem Sciences.

Diversification Opportunities for Pmv Pharmaceuticals and Accustem Sciences

-0.22
  Correlation Coefficient

Very good diversification

The 3 months correlation between Pmv and Accustem is -0.22. Overlapping area represents the amount of risk that can be diversified away by holding Pmv Pharmaceuticals and Accustem Sciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Accustem Sciences and Pmv Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pmv Pharmaceuticals are associated (or correlated) with Accustem Sciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Accustem Sciences has no effect on the direction of Pmv Pharmaceuticals i.e., Pmv Pharmaceuticals and Accustem Sciences go up and down completely randomly.

Pair Corralation between Pmv Pharmaceuticals and Accustem Sciences

Given the investment horizon of 90 days Pmv Pharmaceuticals is expected to under-perform the Accustem Sciences. But the stock apears to be less risky and, when comparing its historical volatility, Pmv Pharmaceuticals is 6.99 times less risky than Accustem Sciences. The stock trades about -0.08 of its potential returns per unit of risk. The Accustem Sciences is currently generating about 0.03 of returns per unit of risk over similar time horizon. If you would invest  36.00  in Accustem Sciences on November 29, 2024 and sell it today you would lose (11.00) from holding Accustem Sciences or give up 30.56% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy95.16%
ValuesDaily Returns

Pmv Pharmaceuticals  vs.  Accustem Sciences

 Performance 
       Timeline  
Pmv Pharmaceuticals 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Pmv Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. Even with latest unfluctuating performance, the Stock's basic indicators remain invariable and the latest agitation on Wall Street may also be a sign of long-running gains for the enterprise retail investors.
Accustem Sciences 

Risk-Adjusted Performance

Weak

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Accustem Sciences are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively weak basic indicators, Accustem Sciences unveiled solid returns over the last few months and may actually be approaching a breakup point.

Pmv Pharmaceuticals and Accustem Sciences Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Pmv Pharmaceuticals and Accustem Sciences

The main advantage of trading using opposite Pmv Pharmaceuticals and Accustem Sciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pmv Pharmaceuticals position performs unexpectedly, Accustem Sciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Accustem Sciences will offset losses from the drop in Accustem Sciences' long position.
The idea behind Pmv Pharmaceuticals and Accustem Sciences pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.

Other Complementary Tools

ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
CEOs Directory
Screen CEOs from public companies around the world
Equity Valuation
Check real value of public entities based on technical and fundamental data
Money Managers
Screen money managers from public funds and ETFs managed around the world
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges